Related Experiment Videos
Distinction between dopaminergic and serotonergic components of neuroleptic binding sites in limbic brain areas
Biochemical Pharmacology
|January 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Agonist-induced desensitization of 5-HT(2) receptors on cultured calf aortic smooth muscle cells.
Neurochemistry international·2009
Effects of lesions on (3)H-apomorphine and (3)H-spiperone stereospecific binding sites in subcellular fractions of rat striatum.
Neurochemistry international·2009
Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
Bioorganic & medicinal chemistry·2006
Synthesis and biodistribution of [(11)C]R116301, a promising PET ligand for central NK(1) receptors.
Bioorganic & medicinal chemistry·2005
Zinc gluconate attenuates oxaliplatin-induced pulmonary injury via suppressing the TLR4/NF-κB signaling.
Biochemical pharmacology·2026
Colchicine reduces aortic dissection and aneurysm formation in mice by inhibiting the IL-17A/RA-MAPK pathway.
Biochemical pharmacology·2026
RNF5: an emerging therapeutic target for modulating immunity and metabolism.
Biochemical pharmacology·2026
Vitamin K3 attenuates STING-agonist-induced signaling and imiquimod-induced psoriasis-like inflammation.
Biochemical pharmacology·2026
Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.
The Journal of membrane biology·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026